UNESCO Finalises Ethical Guidelines for Neurotechnology Development
Summary:
UNESCO delegates established nine ethical principles governing neurotechnologies, focusing on protecting user rights and preventing misuse of brain data.
Kymera’s Protein Degradation Drug Shows Promise Against Inflammatory Conditions
Summary:
Kymera’s KT-621 successfully degraded STAT6 protein in trials, potentially offering oral treatment as powerful as injectable Dupixent for inflammation.
Kura and Syndax Race for First AML Drug Approval with Menin Inhibitors
Summary:
Both companies received FDA priority review for acute myeloid leukaemia treatments, with Kura’s ziftomenib showing 23% complete remission
Biotech Companies Urge Tariff Exemptions for Rare Disease and Complex Therapies
Summary:
Industry groups request exemptions from proposed pharmaceutical tariffs, citing risks to patient access and specialized manufacturing requirements.
Research Websites Face Massive Disruption from AI Training Data Bots
Summary:
Scholarly publishers report overwhelming bot traffic scraping content for AI training, causing server overloads and service disruptions for users.
